-
September 18, 2017 Lupin appoints Jim Loerop as Chief Corporate Development Officer
-
September 13, 2017 Lupin receives FDA approval for generic Flagyl® Tablets
-
September 11, 2017 Lupin receives FDA approval for generic Vibra-Tabs® Tablet
-
September 4, 2017 Lupin launches generic Benicar® tablets in the US
-
August 31, 2017 Lupin launches generic Fosrenol Chewable Tablets in the US
-
August 30, 2017 NHI Drug Price Listing for Bipresso® Extended Release Tablets for the Improvement of Depressive Symptoms Associated with Bipolar Disorder Announced
-
August 23, 2017 Lupin launches generic Seroquel XR® tablets in the US
-
August 21, 2017 Lupin receives EIR from US FDA for Aurangabad, April 2017 Inspection
-
August 14, 2017 Lupin’s alliance partner Natco receives FDA approval for generic Fosrenol Chewable Tablets
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications